Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Oncotarget|November 18, 2014
Cooperative interactions between p53 and NFκB enhance cell plasticityAlessandra Bisio, Judit Zámborszky, Sara Zaccara, et al.EMBO Reports|October 27, 2023
PLK1 promotes the mitotic surveillance pathway by controlling cytosolic 53BP1 availabilityMatteo Burigotto, Vincenza Vigorito, Colin Gliech, et al.Natural Product Research|October 10, 2019
Apigenin rich-Limonium duriusculum (de Girard) Kuntze promotes apoptosis in HCT116 cancer cellsMeriem Hadjer Hamadou, Messaoud Kerkatou, Pamela Gatto, et al.Plos One|June 16, 2011
p53 transactivation and the impact of mutations, cofactors and small molecules using a simplified yeast-based screening systemVirginia Andreotti, Yari Ciribilli, Paola Monti, et al.DNA Repair|January 10, 2008
Rev1 and Polzeta influence toxicity and mutagenicity of Me-lex, a sequence selective N3-adenine methylating agentPaola Monti, Yari Ciribilli, Debora Russo, et al.Molecular Cancer Research : MCR|February 24, 2011
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomesPaola Monti, Chiara Perfumo, Alessandra Bisio, et al.Journal of Clinical Medicine|June 27, 2024
Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast CancerAntonella Ferro, Michela Campora, Alessia Caldara, et al.Bioscience Reports|December 3, 2019
P63 modulates the expression of the WDFY2 gene which is implicated in cancer regulation and limb developmentPaola Monti, Yari Ciribilli, Giorgia Foggetti, et al.Oncotarget|October 27, 2015
The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 bindingAlessandra Bisio, Elisa Latorre, Virginia Andreotti, et al.Human Molecular Genetics|January 23, 2010
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanomaAlessandra Bisio, Sabina Nasti, Jennifer J Jordan, et al.Pageof 5